DOI:
10.1055/s-00000031
Klinische Monatsblätter für Augenheilkunde
LinksClose Window
References
Takeda A, Hata Y, Shiose S. et al.
Suppression of experimental choroidal neovascularization utilizing KDR selective receptor tyrosine kinase inhibitor.
Graefes Arch Clin Exp Ophthalmol 2003; 241: 765-772
We do not assume any responsibility for the contents of the web pages of other providers.